Back
F
Frank G. Holz
university of bonn
105H-index
1.7KPaper Count
4.9WCitation Count
Published Papers 367
Publication Date
CRIMSON: A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy (Nov, 10.1007/s00347-025-02345-0, 2025)
Ophthalmologie
IF0.6
CRIMSON: A multicenter, randomized, sham-controlled, double-blind, 72-week study to investigate the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal administration of BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy
OPHTHALMOLOGIE
IF0.6

